<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Health and Population Sciences</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/76352B57-0623-44D3-B54F-9A7A3AF470B3"><gtr:id>76352B57-0623-44D3-B54F-9A7A3AF470B3</gtr:id><gtr:firstName>Wiebke</gtr:firstName><gtr:surname>Arlt</gtr:surname><gtr:orcidId>0000-0001-5106-9719</gtr:orcidId><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G116%2F172"><gtr:id>24C70C7D-B4E8-41F2-AC4A-FE95A363B31F</gtr:id><gtr:title>Pre-receptor regulation of dehydroepiandrosterone synthesis, metabolism and action</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G116/172</gtr:grantReference><gtr:abstractText>DHEA is a hormone produced by the adrenal gland, which also secretes cortisol and aldosterone, regulators of stress, blood pressure and fluid balance, while DHEA serves as a precursor for sex steroid generation. Notably, only humans and some non-human primates show an age-specific variation in DHEA production. While babies have almost undetectable levels, a sharp rise occurs during primary school age with maximum levels around age 30, followed by a continuous decline with ageing. One part of this research will address the regulation of DHEA synthesis by the enzyme P450c17, analysing its interaction with another enzyme, P450 oxidoreductase (OR) as we recently identified OR mutations in patients with an inherited form of adrenal failure. All patients with adrenal failure generally suffer from DHEA deficiency as do patients receiving chronic glucocorticoid treatment, e.g. for asthma or rheumatic diseases, currently 1% of the UK population - 3% in persons aged over 70 years. Glucocorticoid excess leads to obesity, diabetes, osteoporosis, reduced muscle mass and recurrent infections. Therefore, this research will systematically address the action of DHEA in tissues affected by glucocorticoids, i.e. bone, liver, adipose tissue and immune cells. Preliminary findings suggest that DHEA may oppose glucocorticoid action in these tissues. Therefore this research will help to identify beneficial effects of DHEA in major human diseases.</gtr:abstractText><gtr:technicalSummary>Dehydroepiandrosterone (DHEA) and its sulphate ester DHEAS are secreted in large amounts by the zona reticularis of the human adrenal. Only humans and some non-human primates exhibit an age-specific pattern of DHEA secretion, with a rise at 6-10 years of age (adrenarche) and a steady decline from intra-individiual maximum levels after the third decade of life (adrenopause). Underlying regulatory processes have remained elusive and fostered major interest in the steroidogenic enzyme responsible for DHEA biosynthesis, P450c17. We have recently revealed the molecular basis of a new variant of congenital adrenal hyperplasia, which biochemically is associated with P450c17 deficiency, but in fact is explained by inactivating mutations in P450 oxidoreductase (OR), the enzyme crucially involved in electron transfer from NADPH to P450c17. The first part of this research aims at investigating the role of OR in DHEA biosynthesis. This novel link of redox potential to control of DHEA biosynthesis will be studied by a variety of genetic, cellular and molecular approaches including bacterial and yeast expression systems. The second part of the proposed research aims at investigation of tissue-specific action and pre-receptor modulation of DHEA, which mainly exerts its action indirectly, after downstream conversion to sex steroids and intermediate steroids with potentially distinct activity. Patients with adrenal insufficiency suffer from pathological DHEA deficiency and DHEA replacement in this group confers significant beneficial effects. Chronic glucocorticoid excess invariably suppresses DHEA synthesis, so that patients receiving pharmacological glucocorticoid treatment also suffer from premature, severe DHEA deficiency. The impact of this on the incidence and severity of glucocorticoid-associated morbidity (insulin resistance, central adiposity, reduced muscle mass, osteoporosis, increased prevalence of infections) is unknown. Results from rodent experiments suggest that DHEA stimulates the immune response, enhances bone formation, improves insulin sensitivity and reduces fat mass, thereby opposing glucocorticoid action. However, rodent adrenals do not synthesize DHEA which limits the value of rodent models for investigation of DHEA action and human-based experiments are largely lacking. Thus the second part of this research programme seeks to investigate the pre-receptor modulation of DHEA action in major human target tissues of both DHEA and glucocorticoids, specifically immune cells, adipose tissue, bone and liver, employing in vivo and in vitro approaches. Research will focus on the hypothesis that DHEA exerts tissue-specific anti-glucocorticoid action which may be mediated at the pre-receptor level. The results generated by this work programme will further our understanding of the role of DHEA in human disease.</gtr:technicalSummary><gtr:fund><gtr:end>2009-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1063490</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Commission</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>EuroDSD Consortium</gtr:description><gtr:id>ABF0CC62-EF8C-492C-A442-CA76B51923BA</gtr:id><gtr:impact>There is indeed an output as the EU FP7 collaborative network has been funded</gtr:impact><gtr:outcomeId>720A01FFD27-1</gtr:outcomeId><gtr:partnerContribution>increased collaboration and networking across Europe</gtr:partnerContribution><gtr:piContribution>I am the workpackage leader for steroid analysis/steroid metabolomics for this Collaborative Research Network, which is EU FP7 funded and is dedicated to the investigation of the molecular pathogenesis of disordered sex development, expertise arising from my MRC Senior Clinical Fellowship</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Programme Grant</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>D8D6B89F-3F13-4089-9384-01D6E8E34882</gtr:id><gtr:outcomeId>37141E6B9850</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>90000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ESPE Research Training Fellowship</gtr:description><gtr:end>2010-05-02</gtr:end><gtr:fundingOrg>European Society of Pediatric Endocrinology (ESPE)</gtr:fundingOrg><gtr:id>AA08B69E-BA85-4426-AB08-25356A69CA7D</gtr:id><gtr:outcomeId>EF1CA1D62170</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>845000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Biomarkers Grant</gtr:description><gtr:end>2012-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>9AA3F01D-AE3F-4F74-8A59-101D5566C4B6</gtr:id><gtr:outcomeId>94DC123215E0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>170000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Marie Curie Intra-European Fellowship</gtr:description><gtr:end>2010-02-02</gtr:end><gtr:fundingOrg>Marie Sklodowska-Curie Actions</gtr:fundingOrg><gtr:id>01DB3FC3-881A-47E5-A263-1463BAF9274A</gtr:id><gtr:outcomeId>43C6E2BF5D00</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>272165</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC RTF</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/J011592/1</gtr:fundingRef><gtr:id>6D0D1529-AEEA-4F2A-B136-40413CF82CD3</gtr:id><gtr:outcomeId>FskECSfSS8H</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1800000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>European Commission FP7 - Marie Curie Initial Training Network (Multi-Site ITN)</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Marie Sklodowska-Curie Actions</gtr:fundingOrg><gtr:id>2BE70853-546C-4C2F-A10A-34CD4E8BAB22</gtr:id><gtr:outcomeId>svdYNXLQKyf0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Birmingham Children's Hospital Research Foundation, Small Project Grant</gtr:description><gtr:end>2009-08-02</gtr:end><gtr:fundingOrg>BCH Charities</gtr:fundingOrg><gtr:id>D89C43F7-C2E7-45B9-82F4-129CFA606FE5</gtr:id><gtr:outcomeId>9B24B03111C0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Targeted Priority Studentship Programme</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>1ADB0932-A58C-4754-AFC8-956BF4F34C0C</gtr:id><gtr:outcomeId>F05D308235A0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>45000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC DTA PhD studentship</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>02D47629-1509-45AC-9898-BD3EEE984391</gtr:id><gtr:outcomeId>AB5CBE3FA2A0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>750000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Clinician Scientist Fellowship</gtr:description><gtr:end>2011-11-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>A19452AB-28FD-44D1-AE77-B508E9FF38CC</gtr:id><gtr:outcomeId>9E5025E414A0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>7000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust 4-year Combined PhD Training Programme</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>E756C27A-A13A-4593-B5B0-3724D0F41A2A</gtr:id><gtr:outcomeId>A4F2937B0DD0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>225000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ESRC - Interdisciplinary Project Grant (New Dynamics of Ageing) (RES-356-25-0011)</gtr:description><gtr:end>2012-08-02</gtr:end><gtr:fundingOrg>Economic and Social Research Council</gtr:fundingOrg><gtr:fundingRef>RES-356-25-0011</gtr:fundingRef><gtr:id>8A4D2FFA-5205-433B-8332-F25A8AB19721</gtr:id><gtr:outcomeId>qGaMovBjeNK0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>160000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>FP7 EuroDSD Collaborative Grant</gtr:description><gtr:end>2011-08-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>5AF1B67E-4C21-49FE-8F49-29AD7C0B8508</gtr:id><gtr:outcomeId>C49DB09E9930</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>360000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Marie Curie European Fellowship</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>4EA6F65E-8A25-47A2-96EF-E8BD787B858C</gtr:id><gtr:outcomeId>54645a5a8ad345.89528958</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>309491</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant (092283) The role of DHEA sulfation in the pre-receptor regulation of androgen excess</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>13EA1F7B-5BD0-4149-9CB7-18616BAC198F</gtr:id><gtr:outcomeId>nJzE4PLgYF30</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-12-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Membership in the MRC Training and Career Oversight Group</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C452E263-F70A-4541-B4C1-835173FB66E0</gtr:id><gtr:outcomeId>114A04CDFAE</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>8845145F-2430-4F39-A732-0200D4AE694E</gtr:id><gtr:title>Steroid 17alpha-hydroxylase deficiency: functional characterization of four mutations (A174E, V178D, R440C, L465P) in the CYP17A1 gene.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/755d4212349fef96239b030c4dab9f4f"><gtr:id>755d4212349fef96239b030c4dab9f4f</gtr:id><gtr:otherNames>Dhir V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>43A35F98BB1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CA5D4FA-0469-4797-B924-2226A4F1F882</gtr:id><gtr:title>The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer.</gtr:title><gtr:parentPublicationTitle>European urology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58bfd71fbbd42020ba6ceca87a1fcda7"><gtr:id>58bfd71fbbd42020ba6ceca87a1fcda7</gtr:id><gtr:otherNames>Shaw GL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0302-2838</gtr:issn><gtr:outcomeId>56e11c5df0b904.48234589</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>813C8FAA-E9F5-4B3A-8893-BB4ADEDC6917</gtr:id><gtr:title>Genetics of congenital adrenal hyperplasia.</gtr:title><gtr:parentPublicationTitle>Best practice &amp; research. Clinical endocrinology &amp; metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e137afff12d4533ad673529045e90711"><gtr:id>e137afff12d4533ad673529045e90711</gtr:id><gtr:otherNames>Krone N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1521-690X</gtr:issn><gtr:outcomeId>6A0FF8A18C1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08019AB6-3750-4DA9-940C-EC2E56204A92</gtr:id><gtr:title>Prenatal diagnosis of P450 oxidoreductase deficiency (ORD): a disorder causing low pregnancy estriol, maternal and fetal virilization, and the Antley-Bixler syndrome phenotype.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5f777362d2ef8232dd82743bd78b12b"><gtr:id>e5f777362d2ef8232dd82743bd78b12b</gtr:id><gtr:otherNames>Shackleton C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1552-4825</gtr:issn><gtr:outcomeId>83FA330D820</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0F1345A-E80F-4690-953F-8129C1E954F5</gtr:id><gtr:title>Congenital adrenal hyperplasia and P450 oxidoreductase deficiency.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e137afff12d4533ad673529045e90711"><gtr:id>e137afff12d4533ad673529045e90711</gtr:id><gtr:otherNames>Krone N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>C0C8114A657</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D933A976-3051-4E3D-826E-F198CFBA11E0</gtr:id><gtr:title>The approach to the adult with newly diagnosed adrenal insufficiency.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebfa08c2a75ffac43dcfc6bc9fac293d"><gtr:id>ebfa08c2a75ffac43dcfc6bc9fac293d</gtr:id><gtr:otherNames>Arlt W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>345AF0600BE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1196593F-B022-404D-8704-D391BE35383E</gtr:id><gtr:title>Linking Antley-Bixler syndrome and congenital adrenal hyperplasia: a novel case of P450 oxidoreductase deficiency.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f91a0356d37f80818b279df8d48b047"><gtr:id>1f91a0356d37f80818b279df8d48b047</gtr:id><gtr:otherNames>Williamson L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1552-4825</gtr:issn><gtr:outcomeId>0592A85D59A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E260E08-1F2A-424A-B646-9F269B8C59D7</gtr:id><gtr:title>Adult consequences of congenital adrenal hyperplasia.</gtr:title><gtr:parentPublicationTitle>Hormone research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebfa08c2a75ffac43dcfc6bc9fac293d"><gtr:id>ebfa08c2a75ffac43dcfc6bc9fac293d</gtr:id><gtr:otherNames>Arlt W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0301-0163</gtr:issn><gtr:outcomeId>6A5D8896B14</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6524EE2A-7670-4741-AD16-FBA7DEDE6C9D</gtr:id><gtr:title>Adrenal corticosteroid biosynthesis, metabolism, and action.</gtr:title><gtr:parentPublicationTitle>Endocrinology and metabolism clinics of North America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebfa08c2a75ffac43dcfc6bc9fac293d"><gtr:id>ebfa08c2a75ffac43dcfc6bc9fac293d</gtr:id><gtr:otherNames>Arlt W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0889-8529</gtr:issn><gtr:outcomeId>56F3872F4BE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BB5DD6B-2FA6-4765-AC5E-1F6559207FE6</gtr:id><gtr:title>DHEA: why, when, and how much--DHEA replacement in adrenal insufficiency.</gtr:title><gtr:parentPublicationTitle>Annales d'endocrinologie</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0fb4c6de4158c5391f875d09d469d96"><gtr:id>d0fb4c6de4158c5391f875d09d469d96</gtr:id><gtr:otherNames>Allolio B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0003-4266</gtr:issn><gtr:outcomeId>2906AB5BB67</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2541050-7731-4CD4-926F-7AFDC3CA9638</gtr:id><gtr:title>No evidence for hepatic conversion of dehydroepiandrosterone (DHEA) sulfate to DHEA: in vivo and in vitro studies.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2d1090dcbd7335c48b02c290413d7ad"><gtr:id>c2d1090dcbd7335c48b02c290413d7ad</gtr:id><gtr:otherNames>Hammer F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>698966FCBEB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1CAAE02-9A99-460E-9535-F523BC8F9517</gtr:id><gtr:title>Congenital adrenal hyperplasia.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03936bc8579533a5ce1f82737025978d"><gtr:id>03936bc8579533a5ce1f82737025978d</gtr:id><gtr:otherNames>El-Maouche D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>5aa65bdc333d19.38130948</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C44C0723-5CE8-4F8C-B5AE-7DD5DBFC5C61</gtr:id><gtr:title>Adrenal crisis causing critical illness related reversible myocardial dysfunction.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac7697bc61684200b8357127375ee26d"><gtr:id>ac7697bc61684200b8357127375ee26d</gtr:id><gtr:otherNames>Sherlock M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>7AF8CE66056</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FA00E0A-875D-4328-A6BE-440C42AF06D9</gtr:id><gtr:title>Inactivating PAPSS2 mutations in a patient with premature pubarche.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f957a9c29c4efdfc1c0257d82452bd3b"><gtr:id>f957a9c29c4efdfc1c0257d82452bd3b</gtr:id><gtr:otherNames>Noordam C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>48B05E2C8CF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9787CAE-BFB9-4DFB-98E6-0B67989A6D70</gtr:id><gtr:title>Androgen replacement therapy in women.</gtr:title><gtr:parentPublicationTitle>Current opinion in investigational drugs (London, England : 2000)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebfa08c2a75ffac43dcfc6bc9fac293d"><gtr:id>ebfa08c2a75ffac43dcfc6bc9fac293d</gtr:id><gtr:otherNames>Arlt W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1472-4472</gtr:issn><gtr:outcomeId>DD0D3342DC4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA02426F-C13B-4FE4-A8CA-2B34A84B837D</gtr:id><gtr:title>Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol.</gtr:title><gtr:parentPublicationTitle>European journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25f3ec830f0d034469efbb20665c8c68"><gtr:id>25f3ec830f0d034469efbb20665c8c68</gtr:id><gtr:otherNames>Woods CP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0804-4643</gtr:issn><gtr:outcomeId>56e11c5e40e0b9.15191088</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D346DC0F-F2C9-4ED1-8ECF-7A3F68434B74</gtr:id><gtr:title>Sensing and signaling of oxidative stress in chloroplasts by inactivation of the SAL1 phosphoadenosine phosphatase.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cca692917b82ee1bdcbed630604af7de"><gtr:id>cca692917b82ee1bdcbed630604af7de</gtr:id><gtr:otherNames>Chan KX</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>58b927ca7e4569.22769180</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5436FA3-D400-42CB-A492-E6DB428F2F70</gtr:id><gtr:title>Androgen replacement in women.</gtr:title><gtr:parentPublicationTitle>Annales d'endocrinologie</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebfa08c2a75ffac43dcfc6bc9fac293d"><gtr:id>ebfa08c2a75ffac43dcfc6bc9fac293d</gtr:id><gtr:otherNames>Arlt W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0003-4266</gtr:issn><gtr:outcomeId>CC9FDC0857E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0423685-AB24-48C2-822B-D4D45B76B416</gtr:id><gtr:title>Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f97a453f085d472294acf37daccdeae"><gtr:id>3f97a453f085d472294acf37daccdeae</gtr:id><gtr:otherNames>Jones CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>58b927c9dddcc2.88266943</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1880065-B208-464E-8045-C515688A6A0C</gtr:id><gtr:title>Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine.</gtr:title><gtr:parentPublicationTitle>Critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/428b551210f1b96c66e77ce874840e6a"><gtr:id>428b551210f1b96c66e77ce874840e6a</gtr:id><gtr:otherNames>Marik PE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0090-3493</gtr:issn><gtr:outcomeId>4E3E5602340</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19283CB0-2A76-42E9-9F70-83CD76337090</gtr:id><gtr:title>Dehydroepiandrosterone exerts antiglucocorticoid action on human preadipocyte proliferation, differentiation, and glucose uptake.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff1a931c394f3d3128b66a978c71507c"><gtr:id>ff1a931c394f3d3128b66a978c71507c</gtr:id><gtr:otherNames>McNelis JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0193-1849</gtr:issn><gtr:outcomeId>pm_12491_21_24022868</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B7C7C49-3A7E-4DE8-9455-65DC4DE87705</gtr:id><gtr:title>Characterization of the molecular genetic pathology in patients with 11?-hydroxylase deficiency.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/faac6abb6c85eeae7848b053c83f70a4"><gtr:id>faac6abb6c85eeae7848b053c83f70a4</gtr:id><gtr:otherNames>Mooij CF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>56e11c5ee699b5.84043774</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3EEA6DE-3C00-4E0E-8731-134BEE9C4008</gtr:id><gtr:title>A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1c85acc59b94814cc851bbe5d7c4662"><gtr:id>c1c85acc59b94814cc851bbe5d7c4662</gtr:id><gtr:otherNames>Verma S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>2D04C4485AB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBBD6E9F-7F84-449D-9988-B042AA198B96</gtr:id><gtr:title>Impaired 17,20-Lyase Activity in Male Mice Lacking Cytochrome b5 in Leydig Cells.</gtr:title><gtr:parentPublicationTitle>Molecular endocrinology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db0fa8f4ecccc8e12ec514f73cedca53"><gtr:id>db0fa8f4ecccc8e12ec514f73cedca53</gtr:id><gtr:otherNames>Sondhi V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0888-8809</gtr:issn><gtr:outcomeId>58b927ca0fe9c7.25520311</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8FD256C-0DF8-490E-B2E4-404F5308986A</gtr:id><gtr:title>Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0668daa5660547c47e228b0808975faf"><gtr:id>0668daa5660547c47e228b0808975faf</gtr:id><gtr:otherNames>Hahner S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>31760A99B3F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CBA6DF5-8DBD-4728-9078-93A9D6246A92</gtr:id><gtr:title>Functional characterization of three CYP21A2 sequence variants (p.A265V, p.W302S, p.D322G) employing a yeast co-expression system.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/445436494e02bb7bed53f2b2bc59677e"><gtr:id>445436494e02bb7bed53f2b2bc59677e</gtr:id><gtr:otherNames>Bleicken C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>B1D0E9A2789</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5091122-C25B-4804-A920-6B758C757D70</gtr:id><gtr:title>Dehydroepiandrosterone sulfate directly activates protein kinase C-beta to increase human neutrophil superoxide generation.</gtr:title><gtr:parentPublicationTitle>Molecular endocrinology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b09dc9515751f17ba71b746e43af0649"><gtr:id>b09dc9515751f17ba71b746e43af0649</gtr:id><gtr:otherNames>Radford DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0888-8809</gtr:issn><gtr:outcomeId>AN9sfNKAdWp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57B55708-CEDA-4C6A-9D69-B512813B54DD</gtr:id><gtr:title>Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/464cb5d16f9f70bf8053d060893b2f66"><gtr:id>464cb5d16f9f70bf8053d060893b2f66</gtr:id><gtr:otherNames>O'Reilly MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>546459d83407f8.35363868</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDDA11A1-0A84-445D-A614-F3F129349AD7</gtr:id><gtr:title>Differential inhibition of CYP17A1 and CYP21A2 activities by the P450 oxidoreductase mutant A287P.</gtr:title><gtr:parentPublicationTitle>Molecular endocrinology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/755d4212349fef96239b030c4dab9f4f"><gtr:id>755d4212349fef96239b030c4dab9f4f</gtr:id><gtr:otherNames>Dhir V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0888-8809</gtr:issn><gtr:outcomeId>AD8057B3F5D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07CE1234-F584-4C3C-BBA0-6267BD58BD30</gtr:id><gtr:title>Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebfa08c2a75ffac43dcfc6bc9fac293d"><gtr:id>ebfa08c2a75ffac43dcfc6bc9fac293d</gtr:id><gtr:otherNames>Arlt W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>76D5221472F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>874D7633-C9C3-432E-BC73-3239EB3B2355</gtr:id><gtr:title>Dissociation of serum dehydroepiandrosterone and dehydroepiandrosterone sulfate in septic shock.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebfa08c2a75ffac43dcfc6bc9fac293d"><gtr:id>ebfa08c2a75ffac43dcfc6bc9fac293d</gtr:id><gtr:otherNames>Arlt W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>F8A226A8123</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5614A72-704A-4085-8BFE-E1BBD625EA0D</gtr:id><gtr:title>Adrenal crisis in treated Addison's disease: a predictable but under-managed event.</gtr:title><gtr:parentPublicationTitle>European journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73ffaac9e59ce4ff4c9566ef8432a1d8"><gtr:id>73ffaac9e59ce4ff4c9566ef8432a1d8</gtr:id><gtr:otherNames>White K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0804-4643</gtr:issn><gtr:outcomeId>57E4E42BC53</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F1CAC71-ED66-40EA-B8FD-71B010896764</gtr:id><gtr:title>Biochemical diagnosis of Antley-Bixler syndrome by steroid analysis.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5f777362d2ef8232dd82743bd78b12b"><gtr:id>e5f777362d2ef8232dd82743bd78b12b</gtr:id><gtr:otherNames>Shackleton C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1552-4825</gtr:issn><gtr:outcomeId>A35E43169B3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A09BA753-0CDC-4EC1-A609-D19E527E1503</gtr:id><gtr:title>Androgen therapy in women.</gtr:title><gtr:parentPublicationTitle>European journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebfa08c2a75ffac43dcfc6bc9fac293d"><gtr:id>ebfa08c2a75ffac43dcfc6bc9fac293d</gtr:id><gtr:otherNames>Arlt W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0804-4643</gtr:issn><gtr:outcomeId>AAB5E10DECE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30E5C521-8D23-492E-82D2-F89F50C83F2B</gtr:id><gtr:title>Gorham-Stout disease--stabilization during bisphosphonate treatment.</gtr:title><gtr:parentPublicationTitle>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2d1090dcbd7335c48b02c290413d7ad"><gtr:id>c2d1090dcbd7335c48b02c290413d7ad</gtr:id><gtr:otherNames>Hammer F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0884-0431</gtr:issn><gtr:outcomeId>A728DF38AF6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C51CBC95-B6FA-4873-9B8F-5CE557BD3247</gtr:id><gtr:title>PAPSS2 deficiency causes androgen excess via impaired DHEA sulfation--in vitro and in vivo studies in a family harboring two novel PAPSS2 mutations.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83f881ad14c4d84fa5b07fde7a5d33f1"><gtr:id>83f881ad14c4d84fa5b07fde7a5d33f1</gtr:id><gtr:otherNames>Oostdijk W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>54c96f4940ac60.96227969</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FCE3200-2F88-4736-96E1-04BED3904E0D</gtr:id><gtr:title>Effect of insulin on AKR1C3 expression in female adipose tissue: in-vivo and in-vitro study of adipose androgen generation in polycystic ovary syndrome</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ec4b8cfe929b798bde081f33813e9c7"><gtr:id>5ec4b8cfe929b798bde081f33813e9c7</gtr:id><gtr:otherNames>O'Reilly M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56e11c5e238f08.02484787</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3EDB67E-5C9C-41C4-9D83-A32DEC0FEDA7</gtr:id><gtr:title>Role of ALADIN in human adrenocortical cells for oxidative stress response and steroidogenesis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/302f4efd784e38c5ae1c43f87c1f2939"><gtr:id>302f4efd784e38c5ae1c43f87c1f2939</gtr:id><gtr:otherNames>J?hlen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56e11c5f1deda3.29537029</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20561147-FB73-4B35-8FF3-5B3D797E76EF</gtr:id><gtr:title>A male twin infant with skull deformity and elevated neonatal 17-hydroxyprogesterone: a prismatic case of P450 oxidoreductase deficiency.</gtr:title><gtr:parentPublicationTitle>Endocrine research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb13a5799d430ef6f49ec6a904565c5d"><gtr:id>cb13a5799d430ef6f49ec6a904565c5d</gtr:id><gtr:otherNames>Wudy SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0743-5800</gtr:issn><gtr:outcomeId>69A8B6DBDEE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B803261-FE97-4640-AD1F-0800E1439D8D</gtr:id><gtr:title>Evidence for Increased 5a-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b89edd812002749421aaf570c44ed1d1"><gtr:id>b89edd812002749421aaf570c44ed1d1</gtr:id><gtr:otherNames>Torchen LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>58b927cac2e257.92710253</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E31F8904-BECA-43AD-A0CB-006A35FEC602</gtr:id><gtr:title>The adrenal cortex and sexual differentiation during early human development.</gtr:title><gtr:parentPublicationTitle>Reviews in endocrine &amp; metabolic disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a778a1786442f52c505c44e472624f86"><gtr:id>a778a1786442f52c505c44e472624f86</gtr:id><gtr:otherNames>Asby DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1389-9155</gtr:issn><gtr:outcomeId>D2B83B51BCE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5070731F-EA7F-4314-84FF-56F93378FEED</gtr:id><gtr:title>A new dawn for androgens: Novel lessons from 11-oxygenated C19 steroids.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7a413cb86e62d25836995ec125de6d2"><gtr:id>b7a413cb86e62d25836995ec125de6d2</gtr:id><gtr:otherNames>Pretorius E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn><gtr:outcomeId>58b927ca5d4ea3.63953966</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5FFD2A4-F5AB-41A1-AE6C-2B0787F3B19E</gtr:id><gtr:title>Androgen generation in adipose tissue in women with simple obesity--a site-specific role for 17beta-hydroxysteroid dehydrogenase type 5.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/043700e5151e4b522bfce3bad7093eb3"><gtr:id>043700e5151e4b522bfce3bad7093eb3</gtr:id><gtr:otherNames>Quinkler M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn><gtr:outcomeId>29E50530263</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F97DC52B-F8E2-479B-8ADB-6808A80A030B</gtr:id><gtr:title>P450 oxidoreductase deficiency and Antley-Bixler syndrome.</gtr:title><gtr:parentPublicationTitle>Reviews in endocrine &amp; metabolic disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebfa08c2a75ffac43dcfc6bc9fac293d"><gtr:id>ebfa08c2a75ffac43dcfc6bc9fac293d</gtr:id><gtr:otherNames>Arlt W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1389-9155</gtr:issn><gtr:outcomeId>E0E00D10D2A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC1919EC-5AD8-4330-876A-45D6FA370075</gtr:id><gtr:title>Adrenal insufficiency.</gtr:title><gtr:parentPublicationTitle>Clinical medicine (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebfa08c2a75ffac43dcfc6bc9fac293d"><gtr:id>ebfa08c2a75ffac43dcfc6bc9fac293d</gtr:id><gtr:otherNames>Arlt W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1470-2118</gtr:issn><gtr:outcomeId>B3525EC417A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7ED3AB0F-6AA5-4BAF-978D-C5C969937DA9</gtr:id><gtr:title>Steroid biomarkers and genetic studies reveal inactivating mutations in hexose-6-phosphate dehydrogenase in patients with cortisone reductase deficiency.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a440c1edea41fd8b10866dc9f79cdbc8"><gtr:id>a440c1edea41fd8b10866dc9f79cdbc8</gtr:id><gtr:otherNames>Lavery GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>F73CAFD0DE7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>118B777D-8010-46BF-BB39-2028D7681913</gtr:id><gtr:title>[Hypopituitarism].</gtr:title><gtr:parentPublicationTitle>Der Internist</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2d1090dcbd7335c48b02c290413d7ad"><gtr:id>c2d1090dcbd7335c48b02c290413d7ad</gtr:id><gtr:otherNames>Hammer F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0020-9554</gtr:issn><gtr:outcomeId>BFCF5E8B5B6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD7CD239-E8C1-4D3F-9E09-95CC3E5192C8</gtr:id><gtr:title>Steroid Sulfatase Deficiency and Androgen Activation Before and After Puberty.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a59dd2557fd3beeb2639ff29bf8bdd2e"><gtr:id>a59dd2557fd3beeb2639ff29bf8bdd2e</gtr:id><gtr:otherNames>Idkowiak J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>58b927caa02744.36366388</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90E8D3E1-7EA5-44F2-B309-26A6717A41EB</gtr:id><gtr:title>Sex steroid metabolism in human peripheral blood mononuclear cells changes with aging.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2d1090dcbd7335c48b02c290413d7ad"><gtr:id>c2d1090dcbd7335c48b02c290413d7ad</gtr:id><gtr:otherNames>Hammer F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>11B5F581F31</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F21BC5E-7CFC-4E2C-9CB2-F58E471C1F7D</gtr:id><gtr:title>Nonclassic lipoid congenital adrenal hyperplasia masquerading as familial glucocorticoid deficiency.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/efffd827f4cf03299dd1a9576ea0f846"><gtr:id>efffd827f4cf03299dd1a9576ea0f846</gtr:id><gtr:otherNames>Metherell LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>Nb6icMH4VQh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E959CBDE-D9BF-4637-B9B5-EB844E047C7F</gtr:id><gtr:title>POR R457H is a global founder mutation causing Antley-Bixler syndrome with autosomal recessive trait.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c849e9a4e97f47da75ba6d53712e49e0"><gtr:id>c849e9a4e97f47da75ba6d53712e49e0</gtr:id><gtr:otherNames>Adachi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1552-4825</gtr:issn><gtr:outcomeId>9ABB5F02A46</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B277835A-105B-4E03-8449-202513DAE457</gtr:id><gtr:title>Dehydroepiandrosterone and ageing.</gtr:title><gtr:parentPublicationTitle>Best practice &amp; research. Clinical endocrinology &amp; metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebfa08c2a75ffac43dcfc6bc9fac293d"><gtr:id>ebfa08c2a75ffac43dcfc6bc9fac293d</gtr:id><gtr:otherNames>Arlt W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1521-690X</gtr:issn><gtr:outcomeId>48D58A30093</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46601943-45EA-42AC-B2C4-A2B155E5D3DE</gtr:id><gtr:title>11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/464cb5d16f9f70bf8053d060893b2f66"><gtr:id>464cb5d16f9f70bf8053d060893b2f66</gtr:id><gtr:otherNames>O'Reilly MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>58b927ca381811.81118855</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D799DDF3-FACF-4DE2-866F-E4A2E683DE62</gtr:id><gtr:title>The Regulation of Steroid Action by Sulfation and Desulfation.</gtr:title><gtr:parentPublicationTitle>Endocrine reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2283f1dfd4abf59331b0a9a3939afe36"><gtr:id>2283f1dfd4abf59331b0a9a3939afe36</gtr:id><gtr:otherNames>Mueller JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0163-769X</gtr:issn><gtr:outcomeId>56e11c5ec51994.94235705</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31C9E850-EA6A-4F8C-9652-DF14C1D9600F</gtr:id><gtr:title>Modified-release hydrocortisone to provide circadian cortisol profiles.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57c7e7933f54893a2ead60368a229e39"><gtr:id>57c7e7933f54893a2ead60368a229e39</gtr:id><gtr:otherNames>Debono M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>F5823120110</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BA62648-0E9E-4E16-9A03-FD033510FA3E</gtr:id><gtr:title>Age-specific changes in sex steroid biosynthesis and sex development.</gtr:title><gtr:parentPublicationTitle>Best practice &amp; research. Clinical endocrinology &amp; metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e137afff12d4533ad673529045e90711"><gtr:id>e137afff12d4533ad673529045e90711</gtr:id><gtr:otherNames>Krone N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1521-690X</gtr:issn><gtr:outcomeId>D198343F330</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>991E923E-59FD-4F73-B61F-D1778B6FCAB2</gtr:id><gtr:title>Bilateral Testicular Tumors Resulting in Recurrent Cushing Disease After Bilateral Adrenalectomy.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/684e74d4e19e7c0c07ae93b4a0bfcbdc"><gtr:id>684e74d4e19e7c0c07ae93b4a0bfcbdc</gtr:id><gtr:otherNames>Puar T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>58b927c9b59d02.65419543</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23DCFDCC-81D6-4289-8AB6-37CDBFE0EA43</gtr:id><gtr:title>Hormones and immune function: implications of aging.</gtr:title><gtr:parentPublicationTitle>Aging cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebfa08c2a75ffac43dcfc6bc9fac293d"><gtr:id>ebfa08c2a75ffac43dcfc6bc9fac293d</gtr:id><gtr:otherNames>Arlt W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1474-9718</gtr:issn><gtr:outcomeId>2F1A48FF74B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE7F7D55-6E76-448D-83CE-5631F93E915F</gtr:id><gtr:title>Salivary Cortisone Reflects Cortisol Exposure Under Physiological Conditions and After Hydrocortisone.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57c7e7933f54893a2ead60368a229e39"><gtr:id>57c7e7933f54893a2ead60368a229e39</gtr:id><gtr:otherNames>Debono M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>56e11cc8869226.12836219</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B3C2B2F-19D2-4F9E-B488-51E7681E201E</gtr:id><gtr:title>OX40 ligand and CD30 ligand are expressed on adult but not neonatal CD4+CD3- inducer cells: evidence that IL-7 signals regulate CD30 ligand but not OX40 ligand expression.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/efb06190e040b1cafccac06a8efdd770"><gtr:id>efb06190e040b1cafccac06a8efdd770</gtr:id><gtr:otherNames>Kim MY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>19FF9744AEA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54B8797B-2B7B-4E4B-8910-5936F83E842E</gtr:id><gtr:title>Increased 5 alpha-reductase activity and adrenocortical drive in women with polycystic ovary syndrome.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb97f50e21baa7ef962e721d6ad3a448"><gtr:id>fb97f50e21baa7ef962e721d6ad3a448</gtr:id><gtr:otherNames>Vassiliadi DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>1A5F5AF2B03</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E38863C0-BAED-46A5-A71F-2FBBE48D3DF6</gtr:id><gtr:title>Nomenclature for alleles of the cytochrome P450 oxidoreductase gene.</gtr:title><gtr:parentPublicationTitle>Pharmacogenetics and genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ebf4f81abd36bbda37ae1a137783ed4"><gtr:id>6ebf4f81abd36bbda37ae1a137783ed4</gtr:id><gtr:otherNames>Sim SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1744-6872</gtr:issn><gtr:outcomeId>E92B15174BE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84288910-710E-4D45-973B-27572C4027E7</gtr:id><gtr:title>Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebfa08c2a75ffac43dcfc6bc9fac293d"><gtr:id>ebfa08c2a75ffac43dcfc6bc9fac293d</gtr:id><gtr:otherNames>Arlt W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>E75097BD1C2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5457309-635E-4540-9342-CC6F6E015040</gtr:id><gtr:title>The human fetal adrenal cortex and the window of sexual differentiation.</gtr:title><gtr:parentPublicationTitle>Trends in endocrinology and metabolism: TEM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1b075ce75fd13d97a82d2c0f45d8959"><gtr:id>c1b075ce75fd13d97a82d2c0f45d8959</gtr:id><gtr:otherNames>Hanley NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1043-2760</gtr:issn><gtr:outcomeId>9EEA572B3E0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6233833C-F138-48CB-B0A8-4C4FEDD7203D</gtr:id><gtr:title>Fine tuning for quality of life: 21st century approach to treatment of Addison's disease.</gtr:title><gtr:parentPublicationTitle>Endocrinology and metabolism clinics of North America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/897def9e6641f128d0df385dc5f3ddd9"><gtr:id>897def9e6641f128d0df385dc5f3ddd9</gtr:id><gtr:otherNames>Reisch N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0889-8529</gtr:issn><gtr:outcomeId>76D0C3A8332</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EF9C6BC-B9EB-42FB-9BB7-61D70CA0C266</gtr:id><gtr:title>Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature.</gtr:title><gtr:parentPublicationTitle>Intensive care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/629636eefbeb0ff42c823f2a4476723d"><gtr:id>629636eefbeb0ff42c823f2a4476723d</gtr:id><gtr:otherNames>Meduri GU</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0342-4642</gtr:issn><gtr:outcomeId>88A6B534008</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DE25654-CBB0-4102-A30A-F45CEDEE084B</gtr:id><gtr:title>Primary adrenal insufficiency is associated with impaired natural killer cell function: a potential link to increased mortality.</gtr:title><gtr:parentPublicationTitle>European journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c2fa798f4e6726a0e333148051d4950"><gtr:id>4c2fa798f4e6726a0e333148051d4950</gtr:id><gtr:otherNames>Bancos I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0804-4643</gtr:issn><gtr:outcomeId>58b927c9636ec1.19564952</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7AA36366-4884-4222-99B0-CA73B8C47357</gtr:id><gtr:title>Dehydroepiandrosterone replacement therapy.</gtr:title><gtr:parentPublicationTitle>Seminars in reproductive medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebfa08c2a75ffac43dcfc6bc9fac293d"><gtr:id>ebfa08c2a75ffac43dcfc6bc9fac293d</gtr:id><gtr:otherNames>Arlt W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1526-4564</gtr:issn><gtr:outcomeId>1D94FF371E7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29BB7602-6A5A-42C5-8314-A7613B6F5C84</gtr:id><gtr:title>Society for Endocrinology UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development (Revised 2015).</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0027443994fea85a83181a1292521a7"><gtr:id>d0027443994fea85a83181a1292521a7</gtr:id><gtr:otherNames>Ahmed SF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>56e11c5e8787c9.17931332</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G116/172</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>